Funding for this research was provided by:
Medizinische Fakultät, Universität Duisburg-Essen (IFORES)
Rudolf Ackermann Stiftung (Rudolf-Ackermann-Stiftung (Stiftung für Klinische Infektiologie))
Received: 12 August 2019
Accepted: 8 November 2019
First Online: 21 November 2019
Ethics approval and consent to participate
: The study was approved by the local ethics committees of the participating centers (University Hospital Geneva, 06–100; University Hospital Lausanne, 04/07; University Hospital Bern, KEK-BE 045/07; University Hospital Basel, EKBB 262/06; University Hospital Essen, 12–5149-BO). All patients signed a written informed consent.
: Not applicable.
: Oliver Witzke has received research grants for clinical studies, speaker’s fees, honoraria and travel expenses from Amgen, Astellas, Bristol-Myers Squibb, Chiesi, Janssen-Cilag, MSD, Novartis, Roche, Pfizer, and Sanofi. All the other authors declare that they have no competing interests.